ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2

Go back to ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2
(NASDAQ: PRQR) Delayed: 1.67 +0.03 (1.83%)
Previous Close $1.64    52 Week High $13.33 
Open $1.63    52 Week Low $3.48 
Day High $1.71    P/E N/A 
Day Low $1.60    EPS $0.00 
Volume 720,690